Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,974 | 21,019 | 21,331 | 1,085 | 2,109 |
| Receivables | N/A | N/A | N/A | 261 | 110 |
| TOTAL | $18,240 | $21,320 | $21,830 | $1,503 | $2,501 |
| Non-Current Assets | |||||
| PPE Net | 1,075 | 346 | 263 | 309 | 357 |
| Other Non-Current Assets | 130 | 130 | 28 | 53 | 53 |
| TOTAL | $1,205 | $476 | $291 | $362 | $410 |
| Total Assets | $19,445 | $21,796 | $22,121 | $1,865 | $2,911 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,010 | 433 | 289 | 309 | 159 |
| Accrued Expenses | 2,580 | 2,107 | 2,915 | 1,164 | 1,164 |
| TOTAL | $3,693 | $2,540 | $3,204 | $1,685 | $1,560 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 0 | N/A | 212 | 237 |
| Other Non-Current Liabilities | 0 | 64 | 25 | 0 | 0 |
| TOTAL | $N/A | $64 | $25 | $44 | $35 |
| Total Liabilities | $3,693 | $2,604 | $3,229 | $1,729 | $1,595 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,002 | 10,001 | 10,001 | 1,998 | 2,003 |
| Common Shares | 2,002 | 2,002 | 401 | 401 | 401 |
| Retained earnings | -160,239 | -155,978 | -151,776 | -149,844 | -148,425 |
| Other shareholders' equity | 0 | 0 | 19,072 | 0 | 0 |
| TOTAL | $15,752 | $19,192 | $18,892 | $136 | $1,316 |
| Total Liabilities And Equity | $19,445 | $21,796 | $22,121 | $1,865 | $2,911 |